Recro Expands Development and Manufacturing Relationship With Ensysce Biosciences
15. April 2021 07:00 ET
|
Recro Pharma, Inc.
GAINESVILLE, Ga., April 15, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation...